Skip to content

Naratriptan

Amerge (naratriptan) is a small molecule pharmaceutical. Naratriptan was first approved as Amerge on 1998-02-10. It is used to treat migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 1F, and 5-hydroxytryptamine receptor 1A.
Trade Name Amerge
Common Name Naratriptan
Indication migraine disorders
Drug Class Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives
Naratriptan
Get full access now